세계의 비뇨기과용 초음파 기기 시장 - 규모, 점유율, 동향 분석 보고서 : 유형별, 용도별, 질환별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Urology Ultrasound Devices Market Size, Share & Trends Analysis Report By Type (Handheld, Compact), By Application (Diagnosis, Treatment Planning), By Disease, By End-use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,374,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,782,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,597,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

비뇨기과용 초음파 기기 시장 동향

세계의 비뇨기과용 초음파 기기 시장 규모는 2024년에 12억 1,000만 달러로 평가되었으며, 2025-2030년 동안 CAGR 6.17%를 나타낼 것으로 예측됩니다. 산업성장의 주요 요인으로는 신장결석이나 전립선암 등 비뇨기질환의 유병률 상승, AI 대응과 휴대용 초음파기기 등의 기술진보, 비뇨기 질환에 걸리기 쉬운 고령화 등을 들 수 있습니다. 이러한 요인은 의식 증가와 조기 발견에 대한 노력과 함께 시장 확대에 박차를 가하고 있습니다.

비뇨기과용 초음파 시스템은 다양한 비뇨기과 질환의 진단, 모니터링 및 치료 지침으로 비침습적이고 안전하며 비용 효율적인 방법을 제공하기 때문에 매우 효율적입니다. 실시간 이미징이 가능하며 신장, 방광, 전립선 및 기타 비뇨기 구조를 정확하게 시각화할 수 있기 때문에 신결석, 전립선 비대증(BPH), 전립선암 등의 문제를 발견하는데 필수적입니다. 또한 휴대성이 뛰어나고 사용하기 쉽기 때문에 POC(Point of Care) 진단이나 외래 환자의 설정에 최적으로 보다 신속한 임상 판단을 가능하게 합니다. 도플러 이미지, 3D/4D 기능, AI 통합과 같은 고급 기능은 진단 정확도를 높이고 상세한 치료 계획을 가능하게 합니다. 또한, 비뇨기과의 초음파 검사는 생검, 카테터 유치, 결석 제거와 같은 낮은 침습 절차를 안내하는 데 도움이 되며, 보다 높은 정확도를 보장하고 합병증의 위험을 줄일 수 있습니다. 그 다용도는 수술 후 평가와 만성 비뇨기 질환의 모니터링과 현대의 비뇨기과 의료에 필수적인 도구입니다.

신결석, 전립선 비대증(BPH), 전립선암, 요로 감염(UTI), 방광 기능 장애 등 비뇨기과 질환의 유병률 증가가 시장 성장에 더욱 기여하고 있습니다. 이러한 질병은 인구의 고령화, 앉기 쉬운 라이프 스타일, 식생활, 비만 및 당뇨병률의 상승과 같은 요인으로 인해 점점 흔해지고 있습니다. 예를 들어, 전립선암은 여전히 세계적으로 남성들 사이에서 가장 많이 진단되는 암 중 하나이며, 신장 결석은 매년 수백만명에 영향을 미치고 있기 때문에 효과적인 진단·모니터링 도구에 대한 수요가 높아지고 있습니다. 이러한 질병의 부담 증가는 조기 발견, 치료 계획, 경과 관찰에서 비뇨기과 초음파 시스템의 중요한 역할을 부각시키고 시장 확대를 뒷받침하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 비뇨기과용 초음파 기기 시장의 변수, 동향, 범위

• 시장 계통의 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비뇨기과용 초음파 기기 시장 분석 툴
  • 산업 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 비뇨기과용 초음파 기기 시장 : 유형별, 추정·동향 분석

• 부문 대시보드
• 세계의 비뇨기과용 초음파 유형 시장의 변동 분석
• 세계의 비뇨기과용 초음파 기기 시장 규모와 동향 분석, 유형별, 2018-2030년
• 핸드헬드
• 컴팩트
• 카트/트롤리

제5장 비뇨기과용 초음파 기기 시장 : 용도별, 추정·동향 분석

• 부문 대시보드
• 세계의 비뇨기과 초음파의 용도 시장의 변동 분석
• 세계의 비뇨기과용 초음파 기기 시장 규모와 동향 분석, 용도별, 2018-2030년
• 진단
• 치료 계획
• 시술가이드
• 모니터링
• 스크리닝

제6장 비뇨기과용 초음파 기기 시장 : 질환별, 추정·동향 분석

• 부문 대시보드
• 세계의 비뇨기과 초음파의 질병 시장의 변동 분석
• 세계의 비뇨기과용 초음파 기기 시장 규모와 동향 분석, 질환별, 2018-2030년
• 전립선 질환
• 신장 질환
• 방광장애
• 고환질환
• 수술 후 평가
• 기타 질환

제7장 비뇨기과용 초음파 기기 시장 : 최종 용도별, 추정·동향 분석

• 부문 대시보드
• 세계의 비뇨기과용 초음파의 최종 용도 시장의 변동 분석
• 세계의 비뇨기과용 초음파 기기 시장 규모와 동향 분석, 최종 용도별, 2018-2030년
• 병원과 전문 클리닉
• 화상 진단센터
• 기타

제8장 비뇨기과용 초음파 기기 시장 : 유형, 용도, 질환, 최종 용도에 따른 지역별, 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년과 2030년
• 지역별 시장 대시보드
• 세계 지역 시장 현황
• 시장 규모, 예측 동향 분석, 2018-2030년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제9장 경쟁 구도

• 주요 시장 진출기업에 의한 최근의 동향과 영향 분석
• 기업/경쟁의 분류
• 주요 기업의 시장 점유율 분석, 2024년
• Company Position Analysis
• 기업분류(신흥기업, 이노베이터, 리더)
• 기업 프로파일
  • GE HealthCare
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • Canon Medical Systems
  • Mindray Medical International Limited
  • Samsung Medison Co., Ltd.
  • FUJIFILM SonoSite, Inc.
  • Konica Minolta Inc.
  • Esaote

JHS

영문 목차

영문목차

Urology Ultrasound Devices Market Trends:

The global urology ultrasound devices market size was valued at USD 1.21 billion in 2024 and is expected to grow at a CAGR of 6.17% from 2025 to 2030. Major factors contributing to the industry growth include the rising prevalence of urological disorders like kidney stones and prostate cancer, technological advancements such as AI-enabled and portable ultrasound devices, and the aging population, which is more prone to urological conditions. These factors, coupled with increasing awareness and early detection efforts, are fueling the market's expansion.

Urology ultrasound systems are highly efficient as they provide a non-invasive, safe, and cost-effective method for diagnosing, monitoring, and guiding treatments for various urological conditions. They deliver real-time imaging, enabling accurate visualization of the kidneys, bladder, prostate, and other urological structures, which is essential for detecting issues like kidney stones, benign prostatic hyperplasia (BPH), and prostate cancer. Additionally, their portability and ease of use make them ideal for point-of-care diagnostics and outpatient settings, allowing for faster clinical decisions. Advanced features, such as Doppler imaging, 3D/4D capabilities, and AI integration, enhance diagnostic precision and enable detailed treatment planning. Furthermore, urology ultrasounds assist in guiding minimally invasive procedures like biopsies, catheter placements, and stone removal, ensuring greater accuracy and reducing the risk of complications. Their versatility also extends to post-surgical evaluations and monitoring of chronic urological conditions, making them indispensable tools in modern urology care.

The growing prevalence of urological conditions such as kidney stones, benign prostatic hyperplasia (BPH), prostate cancer, urinary tract infections (UTIs), and bladder dysfunction is further contributing to the market growth. These conditions are becoming increasingly common due to factors such as aging populations, sedentary lifestyles, dietary habits, and rising rates of obesity and diabetes. For instance, prostate cancer remains one of the most diagnosed cancers among men globally, while kidney stones affect millions annually, driving the demand for effective diagnostic and monitoring tools. The increasing burden of these conditions highlights the critical role of urology ultrasound systems in early detection, treatment planning, and follow-up care, thereby propelling market expansion.

Global Urology Ultrasound Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global urology ultrasound devices market report on the basis of type, application, disease, end-use, and region:

• Type Outlook (Revenue, USD Million, 2018 - 2030)
• Handheld
• Compact
• Cart/Trolley
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Diagnosis
• Treatment Planning
• Guidance for Procedures
• Monitoring
• Screening
• Disease Outlook (Revenue, USD Million, 2018 - 2030)
• Prostate Disorders
• Kidney Disorders
• Bladder Disorders
• Testicular Disorders
• Post-Surgical Evaluation
• Other Disorders
• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals & Specialty Clinics
• Diagnostic Imaging Centers
• Other End Users
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. Disease
  • 1.2.4. End Use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
  • 2.2.3. Disease outlook
  • 2.2.4. End use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Urology Ultrasound Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of urological disorders
    • 3.2.1.2. Growing demand for noninvasive diagnosis
    • 3.2.1.3. Rising geriatric population
    • 3.2.1.4. Advancements in technology
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of advanced ultrasound systems
    • 3.2.2.2. Complex regulatory environment
• 3.3. Urology Ultrasound Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Urology Ultrasound Devices Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Urology Ultrasound Type Market Movement Analysis
• 4.3. Global Urology Ultrasound Devices Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Handheld
  • 4.4.1. Handheld market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Compact
  • 4.5.1. Compact market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Cart/Trolley
  • 4.6.1. Cart/trolley market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Urology Ultrasound Devices Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Urology Ultrasound Application Market Movement Analysis
• 5.3. Global Urology Ultrasound Devices Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Diagnosis
  • 5.4.1. Diagnosis market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Treatment Planning
  • 5.5.1. Treatment planning market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Guidance for procedures
  • 5.6.1. Guidance for procedures market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Monitoring
  • 5.7.1. Monitoring market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Screening
  • 5.8.1. Screening market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Urology Ultrasound Devices Market: Disease Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Urology Ultrasound Disease Market Movement Analysis
• 6.3. Global Urology Ultrasound Devices Market Size & Trend Analysis, by Disease, 2018 to 2030 (USD Million)
• 6.4. Prostate Disorders
  • 6.4.1. Prostate disorders market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Kidney Disorders
  • 6.5.1. Kidney disorders market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Bladder Disorders
  • 6.6.1. Bladder disorders market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Testicular Disorders
  • 6.7.1. Testicular disorders market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Post-Surgical Evaluation
  • 6.8.1. Post-surgical evaluation market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. Other Disorders
  • 6.9.1. Other disorders market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Urology Ultrasound Devices Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Urology Ultrasound End Use Market Movement Analysis
• 7.3. Global Urology Ultrasound Devices Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals & Specialty Clinics
  • 7.4.1. Hospitals & Specialty Clinics market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Diagnostic Imaging Centers
  • 7.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Other End Users
  • 7.6.1. Other End Users market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Urology Ultrasound Devices Market: Regional Estimates & Trend Analysis By Type, Application, Disease, End Use

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Competitive scenario
    • 8.5.1.3. Regulatory framework
    • 8.5.1.4. Reimbursement structure
    • 8.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Reimbursement structure
    • 8.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Mexico
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Reimbursement structure
    • 8.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Competitive scenario
    • 8.6.1.3. Regulatory framework
    • 8.6.1.4. Reimbursement structure
    • 8.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement structure
    • 8.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. France
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. Reimbursement structure
    • 8.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. Italy
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. Reimbursement structure
    • 8.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Spain
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Competitive scenario
    • 8.6.5.3. Regulatory framework
    • 8.6.5.4. Reimbursement structure
    • 8.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Norway
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Competitive scenario
    • 8.6.6.3. Regulatory framework
    • 8.6.6.4. Reimbursement structure
    • 8.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Sweden
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Competitive scenario
    • 8.6.7.3. Regulatory framework
    • 8.6.7.4. Reimbursement structure
    • 8.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.8. Denmark
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Competitive scenario
    • 8.6.8.3. Regulatory framework
    • 8.6.8.4. Reimbursement structure
    • 8.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Competitive scenario
    • 8.7.1.3. Regulatory framework
    • 8.7.1.4. Reimbursement structure
    • 8.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement structure
    • 8.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement structure
    • 8.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement structure
    • 8.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Competitive scenario
    • 8.7.5.3. Regulatory framework
    • 8.7.5.4. Reimbursement structure
    • 8.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Competitive scenario
    • 8.7.6.3. Regulatory framework
    • 8.7.6.4. Reimbursement structure
    • 8.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Competitive scenario
    • 8.8.1.3. Regulatory framework
    • 8.8.1.4. Reimbursement structure
    • 8.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. Argentina
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Competitive scenario
    • 8.8.2.3. Regulatory framework
    • 8.8.2.4. Reimbursement structure
    • 8.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Competitive scenario
    • 8.9.1.3. Regulatory framework
    • 8.9.1.4. Reimbursement structure
    • 8.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Competitive scenario
    • 8.9.2.3. Regulatory framework
    • 8.9.2.4. Reimbursement structure
    • 8.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Competitive scenario
    • 8.9.3.3. Regulatory framework
    • 8.9.3.4. Reimbursement structure
    • 8.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Competitive scenario
    • 8.9.4.3. Regulatory framework
    • 8.9.4.4. Reimbursement structure
    • 8.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Key company market share analysis, 2024
• 9.4. Company Position Analysis
• 9.5. Company Categorization (Emerging Players, Innovators and Leaders
• 9.6. Company Profiles
  • 9.6.1. GE HealthCare
    • 9.6.1.1. Company overview
    • 9.6.1.2. Financial performance
    • 9.6.1.3. Product benchmarking
    • 9.6.1.4. Strategic initiatives
  • 9.6.2. Koninklijke Philips N.V.
    • 9.6.2.1. Company overview
    • 9.6.2.2. Financial performance
    • 9.6.2.3. Product benchmarking
    • 9.6.2.4. Strategic initiatives
  • 9.6.3. Siemens Healthineers AG
    • 9.6.3.1. Company overview
    • 9.6.3.2. Financial performance
    • 9.6.3.3. Product benchmarking
    • 9.6.3.4. Strategic initiatives
  • 9.6.4. Canon Medical Systems
    • 9.6.4.1. Company overview
    • 9.6.4.2. Financial performance
    • 9.6.4.3. Product benchmarking
    • 9.6.4.4. Strategic initiatives
  • 9.6.5. Mindray Medical International Limited
    • 9.6.5.1. Company overview
    • 9.6.5.2. Financial performance
    • 9.6.5.3. Product benchmarking
    • 9.6.5.4. Strategic initiatives
  • 9.6.6. Samsung Medison Co., Ltd.
    • 9.6.6.1. Company overview
    • 9.6.6.2. Financial performance
    • 9.6.6.3. Product benchmarking
    • 9.6.6.4. Strategic initiatives
  • 9.6.7. FUJIFILM SonoSite, Inc.
    • 9.6.7.1. Company overview
    • 9.6.7.2. Financial performance
    • 9.6.7.3. Product benchmarking
    • 9.6.7.4. Strategic initiatives
  • 9.6.8. Konica Minolta Inc.
    • 9.6.8.1. Company overview
    • 9.6.8.2. Financial performance
    • 9.6.8.3. Product benchmarking
    • 9.6.8.4. Strategic initiatives
  • 9.6.9. Esaote
    • 9.6.9.1. Company overview
    • 9.6.9.2. Financial performance
    • 9.6.9.3. Product benchmarking
    • 9.6.9.4. Strategic initiatives